Editorial
doi: 10.1056/NEJMe078099.
Epub 2007 May 21.
Rosiglitazone and cardiovascular risk
- PMID: 17517854
- DOI: 10.1056/NEJMe078099
Item in Clipboard
Editorial
Rosiglitazone and cardiovascular risk
N Engl J Med.
.
Free article
No abstract available
Comment in
-
Rosiglitazone--continued uncertainty about safety.N Engl J Med. 2007 Jul 5;357(1):63-4. doi: 10.1056/NEJMe078118. Epub 2007 Jun 5. N Engl J Med. 2007. PMID: 17551160 No abstract available.
-
Rosiglitazone and cardiotoxicity--weighing the evidence.N Engl J Med. 2007 Jul 5;357(1):64-6. doi: 10.1056/NEJMe078117. Epub 2007 Jun 5. N Engl J Med. 2007. PMID: 17551161 No abstract available.
-
Rosiglitazone and cardiovascular risk.N Engl J Med. 2007 Aug 30;357(9):939; author reply 939-40. N Engl J Med. 2007. PMID: 17806134 No abstract available.
Comment on
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21. N Engl J Med. 2007. PMID: 17517853
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
